Prostate Cancer and Prostatic Diseases

Published by: Nature Publishing Group  

People

  1. Scher
    Scher
  2. Eastham
    Eastham
  3. Morris
    Morris
  4. Scardino
    Scardino
  5. Benfante
    Benfante
  6. Carlsson
    Carlsson
  7. Fine
    Fine
  8. Jones
    Jones
  9. Rathkopf
    Rathkopf
  10. Reuter
    Reuter

Groups

  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Genitourinary Oncology Service (22)
  4. Surgery (12)
  5. Urology (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (9)
  7. Sloan Kettering Institute Faculty (9)
  8. Population Sciences Research Program (6)
  9. GSK Faculty (5)
  10. Survivorship Research (5)
Search Within
Formats
  1. Journal Article (35)
  2. Review (4)
  3. Editorial (1)
Groups
  1. Department of Medicine (23)
  2. Solid Tumor Oncology Division (23)
  3. Genitourinary Oncology Service (22)
  4. Surgery (12)
  5. Urology (12)
  6. Molecular Pharmacology and Chemistry Program Faculty (9)

More Groups

People
  1. Howard Scher (8)
  2. James Eastham (7)
  3. Michael Morris (7)
  4. Philip Kantoff (6)
  5. Peter Scardino (5)
  6. Edward Christopher Dee (4)

More People

Years
  1. 2024 (1)
  2. 2023 (5)
  3. 2022 (2)
  4. 2021 (2)
  5. 2020 (3)
  6. 2019 (4)

More Years

Publishers
  1. Nature Publishing Group (40)

Results (40)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Major adverse cardiovascular events of enzalutamide versus abiraterone in prostate cancer: A retrospective cohort study
    Journal Article

    Lee, Y. H. A.; Hui, J. M. H.; Leung, C. H.; Tsang, C. T. W.; Hui, K.; Tang, P.; Chan, J. S. K.; Dee, E. C.; Ng, K.; McBride, S.; more...
    Prostate Cancer and Prostatic Diseases (2024)

    Fulltext@MSK | Save
  • The imperative for clinical trial diversity: Perspectives in the context of prostate-specific membrane antigen-targeted imaging
    Review

    Cho, H. L.; Perni, S.; D’Amico, A. V.; Yamoah, K.; Dee, E. C.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Social determinants of health: Does socioeconomic status affect access to staging imaging for men with prostate cancer
    Review

    Kelly, B. D.; Perera, M.; Bolton, D. M.; Papa, N.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Estimating patient health in prostate cancer treatment counseling
    Journal Article

    Chesnut, G. T.; Tin, A. L.; Fleshner, K. A.; Benfante, N. E.; Vickers, A. J.; Eastham, J. A.; Sjoberg, D. D.; Carlsson, S. V.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Localized prostate cancer disparities in risk group at presentation and access to treatment for Hispanic men
    Journal Article

    Swami, N.; Baez, Y. A.; Franco, I.; Nguyen, T.; Meiyappan, K.; Ton, M.; Jain, B.; Seldon, C.; Ng, K.; Duma, N.; more...
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Real-world use of bone modifying agents in metastatic, castration-resistant prostate cancer
    Journal Article

    Mitchell, A. P.; Mishra Meza, A.; Panageas, K. S.; Lipitz-Snyderman, A.; Farooki, A.; Morris, M. J.
    Prostate Cancer and Prostatic Diseases (2023)

    Fulltext@MSK | Save
  • Racial disparities in treatment delay among younger men with prostate cancer
    Journal Article

    Jain, B.; Yamoah, K.; Lathan, C. S.; Muralidhar, V.; Mahal, B. A.; Nguyen, P. L.; Dee, E. C.
    Prostate Cancer and Prostatic Diseases (2022)

    Fulltext@MSK | Save
  • A randomized controlled trial comparing changes in fitness with or without supervised exercise in patients initiated on enzalutamide and androgen deprivation therapy for non-metastatic castration-sensitive prostate cancer (EXTEND)
    Journal Article

    Harrison, M. R.; Davis, P. G.; Khouri, M. G.; Bartlett, D. B.; Gupta, R. T.; Armstrong, A. J.; McNamara, M. A.; Zhang, T.; Anand, M.; Onyenwoke, K.; more...
    Prostate Cancer and Prostatic Diseases (2022)

    Fulltext@MSK | Save
  • In search of the optimal setting for statin trials in prostate cancer: The power of population-based studies
    Editorial

    Allott, E. H.; Craig, E. L.; Stopsack, K. H.
    Prostate Cancer and Prostatic Diseases (2021)

    Fulltext@MSK | Save
  • Treating the patient and not just the cancer: Therapeutic burden in prostate cancer
    Review

    Spratt, D. E.; Shore, N.; Sartor, O.; Rathkopf, D.; Olivier, K.
    Prostate Cancer and Prostatic Diseases (2021)

    Fulltext@MSK | Save

    • Prostate Cancer and Prostatic Diseases – authorized name for:

    Name ISSN / ISBN Publisher
    Prostate Cancer and Prostatic Diseases 13657852 2017, The Author(s), Under Exclusive Licence To Macmillan Publishers Limited, Part of Springer Nature
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 13657852 2019, Springer Nature America, Inc
    Prostate Cancer and Prostatic Diseases 14765608 Unknown
    Prostate Cancer and Prostatic Diseases 13657852 Unknown
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 13657852 2021, The Author(s)
    Prostate Cancer and Prostatic Diseases 13657852 2020, The Author(s), Under Exclusive Licence To Springer Nature Limited
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 13657852 Macmillan Publishers Limited
    Prostate Cancer and Prostatic Diseases 13657852 The Author(s), Under Exclusive Licence To Springer Nature Limited 2022
    Prostate Cancer and Prostatic Diseases 13657852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 13657852 2021, The Author(s), Under Exclusive Licence To Springer Nature Limited
    Prostate Cancer and Prostatic Diseases 13657852 2022, The Author(s)
    Prostate Cancer and Prostatic Diseases 1365-7852 Springernature
    Prostate Cancer and Prostatic Diseases 1365-7852 Stockton Press
    Prostate Cancer and Prostatic Diseases 1365-7852 Unknown
    Prostate Cancer and Prostatic Diseases 13657852 The Author(s) 2023
    Prostate Cancer and Prostatic Diseases 13657852 2022, The Author(s), Under Exclusive Licence To Springer Nature Limited
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 1476-5608 Nature Publishing Group
    Prostate Cancer and Prostatic Diseases 1365-7852 Nature Publishing Group